Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome Market Insight, Epidemiology and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.

Vasomune Therapeutics Inc., and AnGes Inc., are pleased to announce that they have entered into an agreement to expand the ...

Among children with ARDS on mechanical ventilation (MV), mechanical power can be measured and adjusted to minimize lung injury.

The rise in the incidence of ARDS stimulates the research and development of the drug, as it is likely to provide an appropriate environment for newer products to be profitable. Companies across the ...

Acute respiratory distress syndrome frequently goes unrecognized in ICUs Researchers evaluated intensive care unit incidence and outcomes of acute respiratory distress syndrome to assess clinician ...

As per DelveInsight, the Acute Respiratory Distress Syndrome Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident ...

Data Bridge Market research has a newly released expansive study titled “North America Acute Respiratory Distress Syndrome (ARDS) Market ” which guarantees you will remain better informed than your ...

DelveInsight's'Acute Respiratory Distress Syndrome - Market Insights, Epidemiology and Market Forecast-2023'report provides an overview of the Acute Respiratory Distress Syndrome along with the ...

The "Australia Acute Respiratory Distress Syndrome Market Analysis 2025" report has been added to ResearchAndMarkets.com's offering. The Australia Acute Respiratory Distress Syndrome (ARDS) Market is ...

A team of scientists from Germany has recently conducted a study to investigate the effect of inhaled prostacyclin on the prognosis of acute respiratory distress syndrome (ARDS) induced by coronavirus ...

ARDS companies are MediciNova, Light Chain Biosciences, Boehringer Ingelheim, Genentech, Windtree Therapeutics, Healios, Biohaven Pharmaceutical, ILTOO Pharma. ALBANY ...